HONG KONG – For five years in a row, China has seen the number of adverse effects from pharmaceuticals rise, but while the numbers are negative at first blush they do point to an improved and much broader monitoring network that has increased the country's pharmacovigilance capability.
HONG KONG – For five years in a row, China has seen the number of adverse effects from pharmaceuticals rise, but while the numbers are negative at first blush they do point to an improved and much broader monitoring network that has increased the country's pharmacovigilance capability.
HONG KONG – A dramatic plummeting in the value of publicly listed shares in Mainland China over the last month has wiped out roughly $3 trillion in wealth and raised fears of a collapse in the country's stock market, a collapse that could exacerbate slowing economic growth.
HONG KONG – Regulators in China will start making unannounced inspections at pharmaceutical and medical device companies. "This is the first set of regulations for unannounced inspections in China," said Chao Xu, managing director of Chinese medical device service group Osmunda's Germany branch.
HONG KONG — A dramatic plummeting in the value of publicly listed stocks in China over the last month has wiped out around $3 trillion in wealth, and raised fears of a collapse of the country's stock market that could exacerbate slowing economic growth.
HONG KONG – A dramatic plummeting in the value of publicly listed shares in Mainland China over the last month has wiped out roughly $3 trillion in wealth and raised fears of a collapse in the country's stock market, a collapse that could exacerbate slowing economic growth.
